Objectives The inhibitor of apoptosis (IAP) proteins are critical modulators of
chemotherapeutic resistance in various cancers. To address the alarming emergence of …

The clinical benefits of curcumin as a single agent were demonstrated in patients with
advanced pancreatic cancer in a phase 2 study despite pharmacokinetic analysis showing a …

Abstract Curcumin [(1E, 6E)-1, 7-bis (4-hydroxy-3-methoxyphenyl) hepta-1, 6-diene-3, 5di
one] is the major yellow pigment extracted from turmeric, a commonly used spice, derived …

Although traditional medicines have been used for thousands of years, for most such
medicines neither the active component nor their molecular targets have been very well …

In the interesting paper 'Pharmacological basis for the role of curcumin in chronic diseases:
an age-old spice with modern targets' published in the February issue of Trends in …

Gastrointestinal (GI) cancers are known as frequently occurred solid malignant tumors that
can cause the high rate mortality in the world. Metastasis is a significant destructive feature …

Background Curcumin is herbal compound that has been shown to have anti-cancer effects
in pre-clinical and clinical studies. The anti-cancer effects of curcumin include inhibiting the …

Curcumin is a yellow pigment found in turmeric (Curcuma Longa L.), and is reported, in
recent studies, to have several pharmacological effects, including anti-oxidant, anti …

Curcumin, one of the most studied chemopreventive agents, is a natural compound
extracted from Curcuma longa L. Extensive research over the last half century has revealed …

Curcumin, the key bioactive phytochemical present in turmeric (Curcuma longa L.), is the
most studied natural compound in cancer. Preclinical studies (in vitro and in vitro) and …